This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Multiple Sclerosis
and you are
between 18 and 60
years old
-
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this study is to determine if sexual dysfunction symptoms and quality of life measures in patients with Multiple Sclerosis may be improved in patients that are prescribed Tysabri.

Provided treatments

  • Drug: Tysabri ® (Natalizumab)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01455220. The sponsor of the trial is University of South Florida and it is looking for 45 volunteers for the current phase.
Official trial title:
The Effect of Natalizumab (Tysabri) on Sexual Dysfunction in Multiple Sclerosis